Clinical trial myths during breast cancer awareness month

Share

Among genetics and environmental factors, unopposed estrogen is a cause of breast cancer.

Clinical Research Coordinator for Genesis Cancer Care Institute Kim Turner said, trials can be offered to someone who is at high risk for breast cancer, during early stages of their diagnoses or if the cancer is cured but reoccurs or even spreads.

On Tuesday's Smart Talk we discuss breast cancer risks, the value of early detection and screening, and treatment options. The test looks at 18 genetic variants on blood or saliva that are known to affect a woman's chances of getting breast cancer.


"We also need to develop formal training modules for physicians and surgeons who are treating people with cancer to understand how to begin conversations about employment effects and incorporate those into our routine discussions", says Jagsi. According to the American Cancer Society Cancer Facts & Figures 2017, an estimated 252,710 women in the United States will be diagnosed with breast cancer and 40,610 will die from the disease this year.

Mr Balfour said: "Breast cancer is one of the most common cancers in Scotland - unfortunately most people know of someone affected by this awful disease". Prof Gareth Evans, who led the research into the test at Manchester University Foundation Trust, says women with a BRCA mutation have a risk of breast cancer somewhere between 30% and 90%. "That's more important than just living to avoid breast cancer".

More than 15,000 people will be at Washington Park to spread messages of hope and victory of cancer.

Share